New frontiers in radioembolization
Arian Mansur1, Peiman Habibollahi2, Adam Fang3
1Harvard Medical School, Boston, MA, USA.
Therapeutic Advances in Medical Oncology
|October 7, 2024
Summary
Radioembolization uses targeted radiation beads for liver cancer treatment, evolving from palliative care to curative intent, neoadjuvant therapy, and transplant bridging. This therapy is crucial for managing hepatocellular carcinoma and liver metastasis.
Area of Science:
- Interventional Radiology
- Nuclear Medicine
- Oncology
Background:
- Radioembolization is a transarterial therapy delivering internal radiation via radionuclide-loaded microspheres.
- Its application has expanded beyond palliative care to include curative, neoadjuvant, and bridging therapies for liver conditions.
Purpose of the Study:
- To provide a comprehensive overview of radioembolization techniques.
- To discuss current challenges and emerging developments in the field.
- To highlight advancements in dosimetry, radionuclides, and target tumor applications.
Main Methods:
- Review of current literature and clinical practices in radioembolization.
- Analysis of evolving techniques for radiation delivery and tumor targeting.
- Exploration of new dosimetry methodologies and radionuclide agents.
Main Results:
- Radioembolization is increasingly utilized for hepatocellular carcinoma and liver metastasis.
- The therapy's role has broadened significantly, offering versatile treatment options.
- Novel developments are enhancing precision and expanding the scope of radioembolization.
Conclusions:
- Radioembolization is a vital therapeutic option for liver malignancies.
- Ongoing advancements promise improved efficacy and wider applicability.
- Further research into new techniques and targets will continue to shape its role in oncology.
